Key Highlights

  • United States Antimony (NYSEAMERICAN:UAMY) rose 11% to USD 3.18 on Monday, October 19, 2026, after reporting higher third-quarter deliveries under its Defense Logistics Agency supply contract.
  • The sole-source contract is worth up to USD 245 million, with USD 57.3 million of cumulative orders awarded, and the company built inventory to USD 21.6 million to support deliveries.
  • The 1,527% rise in basic earnings per share starts from a near-zero base. Second-quarter 2026 revenue was USD 7.9 million and net income about USD 0.1 million.
  • Full-year 2026 revenue guidance was cut to USD 60 million to USD 75 million, average selling prices fell 52% year on year and the shares were down about 37% for the year.

What Drove the October 19 Rally

United States Antimony (NYSEAMERICAN:UAMY) mines and processes antimony, a critical mineral used in flame retardants, batteries and defence munitions. Its shares rose 11% to USD 3.18 on Monday, October 19, 2026, and traded near USD 3.19 early in the session on Wednesday, October 21, valuing the company at about USD 480 million. The rally followed a report of higher third-quarter deliveries under a sole-source Defense Logistics Agency contract worth up to USD 245 million, with USD 57.3 million of orders awarded so far. Rare earth peers such as USA Rare Earth (NASDAQ:USAR) fell about 3% the same day. Management expects antimony near USD 10 per pound for the rest of the year. Four pending grant applications with the Departments of Energy and War total USD 275 million.

Why the EPS Growth Rests on a Tiny Base

The 1,527% figure for United States Antimony (NYSEAMERICAN:UAMY) is a low-base effect rather than durable operating improvement. When prior earnings sit close to zero, a small change in profit produces a very large percentage. The second quarter shows the scale: revenue of USD 7.9 million and net income of about USD 0.1 million. Pricing then turned against the company. Average selling prices fell 52% year on year, and full-year revenue guidance was cut to USD 60 million to USD 75 million, which sent the shares down about 25% when it was announced. Trailing price to earnings is not meaningful at these profit levels. The stock trades on contract volumes, grants and the strategic value of domestic supply rather than on current earnings.

Risks and What to Watch

The first risk for United States Antimony (NYSEAMERICAN:UAMY) is price, because a further fall in antimony would cut revenue even as volumes rise. The second is execution: meeting guidance requires a sharp increase in deliveries in the second half, including output from the Bolivian facility, which is expected to run at 150 tons per month. The third is working capital, since USD 21.6 million of inventory ties up cash until contract deliveries are paid. Grant decisions could add funding, but none is assured. Investors should watch third-quarter results for revenue against the USD 60 million to USD 75 million guide, new contract orders and the outcome of the USD 275 million grant applications.

Where Things Stand

The answer is that United States Antimony (NYSEAMERICAN:UAMY) jumped 11% because defence deliveries rose, not because earnings have become durable. The 1,527% EPS growth reflects a near-zero base, while a 52% fall in selling prices forced a lower revenue guide. The shares near USD 3.19 sit near the bottom of a 52-week range that reached about USD 13.75. The next catalysts are third-quarter results, new contract orders and grant decisions. Guidance is not a guarantee and this is not investment advice.